YPT11 Antibody

What is YPT11 and why is it important in cell biology research?

YPT11 is a rab-type small GTPase in Saccharomyces cerevisiae that plays crucial roles in organelle inheritance during cell division. Its significance stems from:

• Formation of complexes with Myo2p (a class V myosin) at its tail domain, serving as a molecular motor adaptor

• Direct involvement in mitochondrial inheritance and distribution toward the bud during yeast division

• Contribution to cortical endoplasmic reticulum (cER) and late Golgi inheritance

• Unique structural characteristics compared to other Rab GTPases, including an extended N-terminus and unusual domain architecture

For researchers, YPT11 represents an important model for understanding organelle transport mechanisms and small GTPase regulation in eukaryotic cells.

How does YPT11 protein structure differ from other Rab GTPases?

YPT11 exhibits several unique structural features that distinguish it from typical Rab proteins:

• Exceptional length: At 417 amino acids, YPT11 is approximately twice the size of standard Rab proteins (200+ amino acids)

• Contains an unusually long N-terminal extension (region I) that influences function

• Features an 83-amino acid insert between the P-loop and switch I region of the GTPase domain (region II)

• Possesses a significantly longer C-terminal unstructured region (region III) compared to other Rabs

• Despite these additions, all canonical GTPase and Rab-specific motifs (G1-G3, PM1-PM3, and RabF1-5) are conserved

These structural differences likely contribute to YPT11's specialized functions in organelle inheritance while maintaining core GTPase activity.

What are the key applications for YPT11 antibodies in yeast research?

YPT11 antibodies serve multiple critical applications in yeast research:

• Protein localization studies: Detecting native or tagged YPT11 to determine subcellular distribution patterns, especially during cell division

• Co-immunoprecipitation assays: Investigating protein-protein interactions between YPT11 and binding partners such as Myo2p and Mmr1

• Protein expression level analysis: Quantifying YPT11 abundance, particularly important as it's typically a low-abundance protein whose levels fluctuate throughout the cell cycle

• Post-translational modification detection: Studying phosphorylation states that regulate YPT11 activity and degradation

• Functional domain analysis: Examining how mutations in different YPT11 domains affect protein interactions and cellular functions

These applications enable researchers to comprehensively examine YPT11's roles in mitochondrial inheritance and other cellular processes.

What are the best methods for detecting low-abundance YPT11 protein in yeast cells?

Detecting native YPT11 is challenging due to its naturally low abundance. Effective methodological approaches include:

Enhanced tagging strategies:

• Use high-affinity epitope tags such as 3xHA or TAP tags rather than single epitopes

• Consider fluorescent protein fusions with bright variants (e.g., mNeonGreen) rather than standard GFP for live imaging

• Express tagged YPT11 from its native promoter to maintain physiological expression patterns

Optimized immunoblotting protocols:

• Employ membrane concentration techniques (e.g., methanol-assisted transfer)

• Use signal enhancement systems such as biotin-streptavidin amplification

• Consider extended exposure times with high-sensitivity chemiluminescent substrates

• Load higher protein amounts (75-100 μg per lane) of enriched membrane fractions

Subcellular fractionation:

• Isolate mitochondrial or ER fractions to concentrate YPT11 before detection

• Use density gradient centrifugation to separate membrane fractions

• Validate fractionation quality using established organelle markers

As shown by Lewandowska et al., YPT11 expressed from its native promoter is often below detection limits of standard immunoblotting but can be visualized when modestly overexpressed from regulatable promoters like MET25 .

How should researchers design experiments to study YPT11's role in mitochondrial inheritance?

Designing robust experiments to study YPT11's mitochondrial functions requires careful consideration of multiple factors:

Genetic approaches:

• Utilize ypt11Δ single mutants to observe partial inheritance defects

• Employ ypt11Δ mmr1Δ double mutants for more pronounced phenotypes (~70% of buds lack mitochondria)

• Complement with wild-type or mutant YPT11 variants to assess functional rescue

• Use tetrad analysis for genetic interaction studies with mitochondrial transport machinery components

Visualization strategies:

• Label mitochondria with matrix-targeted fluorescent proteins (e.g., mitochondrial-targeted GFP)

• Alternatively, use vital dyes such as DASPMI for short-term experiments

• Employ time-lapse microscopy to track mitochondrial movement during cell division

• Quantify percentage of medium and large buds containing mitochondria as key metric

Protein localization studies:

• Create mitochondria-tethered YPT11 (ypt11-Mt) by replacing the CCV prenylation motif with the Fis1 transmembrane domain

• Compare with ER-tethered YPT11 (ypt11-ER) and untethered cytoplasmic variants (ypt11ΔCCV)

• Co-visualize YPT11 with mitochondrial markers using dual-color imaging

• Assess mitochondrial morphology and distribution changes upon YPT11 manipulation

Biochemical approaches:

• Analyze binding interactions between YPT11, Myo2p, and Mmr1 using yeast two-hybrid or co-IP assays

• Assess the effect of YPT11 GTPase domain mutations on these interactions

This experimental framework provides comprehensive insights into YPT11's role in mitochondrial inheritance while accounting for redundant mechanisms.

What immunoprecipitation protocols work best for studying YPT11 protein complexes?

Optimized immunoprecipitation (IP) protocols for YPT11 should address its membrane association, low abundance, and specific binding partners:

Buffer composition:

• Use mild detergents (0.5-1% NP-40 or 1% digitonin) to preserve membrane-associated complexes

• Include GTP (0.1-0.5 mM) to stabilize GTPase-effector interactions

• Add phosphatase inhibitors (e.g., sodium fluoride, β-glycerophosphate) to preserve phosphorylation states

• Include protease inhibitor cocktail to prevent degradation during lysis

Experimental approach:

• Tag YPT11 with high-affinity epitopes (HA or FLAG) as demonstrated by Itoh et al.

• Express from native promoter or use mild overexpression systems

• Lyse cells using glass bead disruption in optimized buffer

• Pre-clear lysates with protein A/G beads to reduce background

• Incubate with antibody-conjugated beads for 2-4 hours at 4°C

• Perform stringent washes (at least 4-5) with decreasing detergent concentrations

• Elute complexes using epitope peptide competition or standard methods

Controls and validation:

• Include GTPase-deficient mutants (T104N) as negative controls for effector binding

• Use constitutively active mutants (Q232L) to potentially enhance effector interactions

• Confirm complex formation with reciprocal co-IPs targeting known partners (Myo2p or Mmr1)

• Validate interactions using independent methods (e.g., yeast two-hybrid, as shown in Figure 5D )

This approach successfully demonstrated YPT11's interaction with Myo2p's tail domain in previous studies and can be adapted to identify novel binding partners .

Why might YPT11 antibodies show inconsistent localization patterns across experiments?

Inconsistent YPT11 localization results often stem from several key technical and biological factors:

Expression level dependencies:

• At near-endogenous levels, YPT11 localizes primarily to bud tips and bud necks

• Moderate overexpression shifts localization to include the cell cortex

• High overexpression results in prominent ER localization patterns

• The threshold between these patterns varies with strain background and growth conditions

Cell cycle variations:

• YPT11 exhibits dynamic localization changes throughout the cell cycle

• Expression peaks during G1, immediately before bud emergence

• Localization shifts from bud emergence sites to bud tips to bud necks as division progresses

• Asynchronous cultures show heterogeneous patterns reflecting cell cycle distribution

Technical considerations:

• Fixation methods can disrupt membrane associations (aldehyde-based fixation recommended)

• Antibody accessibility to epitopes may vary between compartments

• Imaging parameters (exposure, gain, deconvolution settings) dramatically affect visible patterns

• Detected patterns may reflect only a subpopulation of total YPT11 due to detection thresholds

To address these challenges, researchers should:

• Carefully control expression levels using titratable promoters

• Synchronize cells when precise localization data is required

• Compare different fixation/permeabilization protocols

• Include multiple controls visualizing known cellular landmarks

As demonstrated by Lewandowska et al., careful attention to expression levels is particularly critical for accurate YPT11 localization studies .

How can researchers overcome difficulties in detecting native YPT11 phosphorylation?

YPT11 phosphorylation detection presents significant challenges due to low abundance and multiple phosphorylation sites. Effective strategies include:

Enhanced enrichment approaches:

• Perform sequential immunoprecipitation (double IP) to increase purity and concentration

• Use phospho-protein enrichment columns prior to YPT11-specific IP

• Consider Phos-tag™ SDS-PAGE to resolve phosphorylated species

• Apply titanium dioxide (TiO₂) enrichment for phosphopeptide analysis

Targeted phosphorylation site analysis:

• Focus on the key regulatory sites identified in previous studies:

  • S8, S77, S79, S80, S158, and S159

• Generate phospho-specific antibodies against these sites

• Use phospho-mimetic (S→D/E) and phospho-deficient (S→A) mutants as controls

• Compare stability and activity of these variants in parallel experiments

Mass spectrometry approaches:

• Use targeted MS methods (MRM/PRM) to detect specific phosphopeptides

• Consider SILAC or TMT labeling to compare phosphorylation under different conditions

• Employ electron-transfer dissociation (ETD) fragmentation to preserve labile phosphorylations

• Analyze samples from cells with phosphatase inhibitors or phosphatase gene deletions

Validation methods:

• Confirm phosphorylation effects using mobility shift assays

• Compare with mutations known to affect YPT11 function and stability

• Correlate phosphorylation status with protein degradation rates

• Measure functional outcomes through mitochondrial inheritance assays

This multi-faceted approach can overcome the challenges in studying YPT11 phosphorylation that regulates its activity and abundance .

What are the best methods to validate YPT11 antibody specificity in yeast cells?

Validating YPT11 antibody specificity requires comprehensive controls to ensure accurate experimental results:

Genetic validation:

• Compare antibody reactivity in wild-type vs. ypt11Δ strains (essential negative control)

• Test against strains expressing tagged YPT11 variants (positive controls)

• Examine cross-reactivity with homologous proteins (other Rab GTPases)

• Use strains with varying YPT11 expression levels to assess sensitivity

Immunological validation:

• Perform peptide competition assays using the immunizing peptide

• Test multiple antibody dilutions to determine optimal signal-to-noise ratio

• Compare monoclonal and polyclonal antibodies targeting different epitopes

• Perform epitope mapping to confirm binding specificity

Experimental validation:

• Correlate immunofluorescence patterns with established YPT11 localization

• Verify antibody detection of known YPT11 interacting partners in co-IP experiments

• Confirm that antibody detects expected molecular weight species (~47kDa for full-length YPT11)

• Demonstrate detection of YPT11 mutants with predictable changes in expression or localization

Technical considerations:

• Include appropriate blocking agents to minimize non-specific binding

• Test multiple sample preparation methods (native vs. denaturing conditions)

• Use highly purified recombinant YPT11 protein as reference standard

• Compare results across different detection methods (Western blot, IF, IP)

This validation framework ensures that experimental results truly reflect YPT11 biology rather than antibody artifacts.

How does YPT11 phosphorylation regulate its activity and degradation in mitochondrial inheritance?

YPT11 phosphorylation represents a sophisticated regulatory mechanism affecting protein function through multiple pathways:

Phosphorylation site dynamics:

• Six primary phosphorylation sites (S8, S77, S79, S80, S158, and S159) have been identified

• Phosphorylation status changes throughout the cell cycle, with increased phosphorylation during mitosis

• Distinct kinases likely target different sites, providing multi-level regulation

• Combinatorial phosphorylation patterns may create a regulatory code for YPT11 activity

Functional consequences:

• Phosphorylation selectively targets active forms of YPT11 for degradation

• Phospho-null mutations (S→A) stabilize the protein, increasing steady-state levels

• Phosphorylation does not directly affect YPT11 binding to effectors (Myo2p and Mmr1)

• Instead, phosphorylation appears to regulate YPT11 turnover rates

Relationship to GTPase cycle:

• Phosphorylation preferentially affects GTP-bound active forms

• This creates a negative feedback loop limiting active YPT11 abundance

• Less active forms maintain higher steady-state levels in the cell

• This regulation ensures appropriate temporal control over mitochondrial inheritance

Experimental evidence:

• Phospho-mutant proteins show altered ability to promote mitochondrial accumulation in buds

• Combining multiple phospho-site mutations produces cumulative effects

• Membrane tethering enhances YPT11 effects more significantly than mutations affecting GTPase state

This regulatory system allows precise spatiotemporal control of YPT11 activity during cell division, ensuring proper mitochondrial inheritance while preventing excessive organelle accumulation in the bud.

How can researchers use YPT11 antibodies to investigate the interplay between mitochondria and ER during inheritance?

Investigating mitochondria-ER coordination during inheritance requires sophisticated experimental approaches:

Co-visualization strategies:

• Perform multi-color immunofluorescence using YPT11 antibodies alongside ER and mitochondrial markers

• Employ super-resolution microscopy (STED, STORM) to resolve contact sites at high precision

• Use proximity ligation assays (PLA) to detect YPT11 at ER-mitochondria contact sites

• Compare localization patterns in wild-type cells versus cells with altered contact site proteins

Genetic manipulation experiments:

• Compare the effects of mitochondria-tethered YPT11 (ypt11-Mt) versus ER-tethered YPT11 (ypt11-ER)

• Analyze YPT11 localization in ERMES complex mutants (mmm1Δ, mdm10Δ, mdm12Δ, mdm34Δ)

• Examine effects of ER morphology mutants on YPT11-dependent mitochondrial inheritance

• Use conditional depletion systems to acutely disrupt ER-mitochondria contacts

Biochemical approaches:

• Perform crosslinking mass spectrometry to identify proteins at ER-mitochondria interfaces

• Isolate mitochondria-associated ER membranes (MAMs) and analyze YPT11 enrichment

• Use BioID or APEX proximity labeling with YPT11 to identify neighboring proteins

• Compare YPT11's interactome in fractions enriched for ER, mitochondria, or contact sites

Functional analyses:

• Quantify the coordination of ER and mitochondrial inheritance in YPT11 mutants

• Analyze inheritance defects when ER-mitochondria contacts are disrupted

• Determine if forced ER-mitochondria tethering can bypass YPT11 requirements

• Measure organelle contacts during the cell cycle in relation to YPT11 activity

This research directly addresses the conflicting models regarding YPT11's role, particularly whether it acts directly on mitochondria or indirectly through ER-mitochondria contacts .

What are the key differences between YPT11 and mammalian Rab GTPases that researchers should consider when designing cross-species experiments?

Cross-species experiments with YPT11 require careful consideration of evolutionary differences:

Sequence and structural divergence:

• YPT11 is unusually large (417aa) compared to typical Rabs (200+aa)

• Contains unique insertions not present in mammalian counterparts

• The extended N-terminus (90aa variable region) lacks direct mammalian homologs

• GTPase domains show conservation, but regulatory regions differ significantly

Localization patterns:

• In yeast, endogenous YPT11 localizes primarily to bud tips/necks and mitochondria

• When expressed in mammalian cells, YPT11 targets transferrin-positive recycling endosomes

• Forms Brefeldin A-induced tubular networks containing Rab11 in mammalian systems

• Different targeting mechanisms may operate in yeast versus mammalian cells

Functional specialization:

• YPT11 specifically regulates organelle inheritance during asymmetric cell division

• Mammalian Rabs typically control vesicular trafficking rather than organelle inheritance

• YPT11 has specialized interactions with Myo2p that may not be conserved with mammalian myosins

• Regulatory mechanisms (phosphorylation patterns, degradation pathways) likely differ

Experimental design considerations:

• Use appropriate expression systems (CMV promoters may cause excessive overexpression)

• Consider codon optimization for mammalian expression

• Include appropriate controls (mammalian Rab11 alongside YPT11)

• Interpret localization patterns carefully, considering differences in cellular architecture

This comparative approach can provide insights into both conserved mechanisms and lineage-specific adaptations in organelle positioning and inheritance.

How should researchers interpret discrepancies between YPT11 antibody-based localization and functional studies?

Resolving discrepancies between localization and functional data requires systematic analysis:

Common sources of discrepancy:

• Detection threshold limitations: Functional concentrations of YPT11 may be below detection limits of standard immunofluorescence

• Expression level artifacts: Overexpression can shift localization patterns from physiological sites

• Temporal dynamics: YPT11 may transiently associate with its functional locations

• Post-fixation relocalization: Membrane-associated proteins can redistribute during sample preparation

Analytical framework:

• Quantitative comparison: Measure YPT11 enrichment across compartments relative to total cellular distribution

• Functional validation: Compare mitochondrial inheritance in strains with YPT11 tethered to different compartments

• Temporal resolution: Use time-lapse imaging with physiological YPT11 expression levels

• Correlative approaches: Combine electron microscopy with fluorescence to resolve precise localization

Reconciliation strategies:

• Use proximity-based approaches (BioID, APEX) rather than direct visualization

• Employ super-resolution techniques to detect small subpopulations

• Compare results across multiple tagging strategies and antibodies

• Correlate with localization of known YPT11 binding partners (Myo2p, Mmr1)

Case study analysis:
Despite rarely being detected on mitochondria by standard methods, YPT11 function requires mitochondrial rather than ER association, as demonstrated by comparing ypt11-Mt and ypt11-ER variants . This exemplifies how targeting experiments can resolve apparent discrepancies between localization and function.

How can researchers distinguish between direct and indirect effects of YPT11 on mitochondrial positioning?

Distinguishing direct versus indirect YPT11 effects requires multiple complementary approaches:

Mechanistic separation experiments:

• Compare mitochondria-tethered YPT11 (ypt11-Mt) with ER-tethered YPT11 (ypt11-ER)

• Only direct mitochondrial targeting rescues inheritance defects in ypt11Δ mmr1Δ strains

• Test whether YPT11 still functions when ER-mitochondria contacts are disrupted

• Examine effects of YPT11 in vitro using purified components and isolated organelles

Temporal resolution studies:

• Track the sequence of events during inheritance using time-lapse microscopy

• Determine whether YPT11 recruitment precedes or follows mitochondrial movement

• Use rapid induction/depletion systems to establish causality in real-time

• Correlate YPT11 activity cycles with organelle movement patterns

Interaction analysis:

• Map the precise binding interface between YPT11 and mitochondrial proteins

• Determine whether YPT11 interacts with mitochondrial outer membrane proteins

• Investigate whether YPT11-Myo2p complexes directly contact mitochondria

• Examine the Mmr1-YPT11 interaction and its role in mitochondrial targeting

Mutational dissection:

• Create separation-of-function mutations that affect only specific YPT11 activities

• Compare GTPase-deficient (T104N) versus constitutively active (Q232L) variants

• Test whether phospho-site mutations differentially affect various YPT11 functions

• Determine which YPT11 domains are essential for mitochondrial versus ER effects

The evidence indicates that YPT11 directly affects mitochondrial inheritance through complex formation with Myo2p, facilitating Myo2p function in mitochondrial distribution toward the bud . This direct model is supported by the observation that only mitochondria-targeted YPT11 rescues inheritance defects .

What are the most promising approaches for developing YPT11 antibodies using AI-guided technologies?

Next-generation YPT11 antibody development can leverage emerging AI-based technologies:

AI-guided epitope selection:

• Utilize computational structural prediction (AlphaFold2) to identify YPT11 surface-exposed regions

• Apply epitope accessibility algorithms to prioritize regions distinct from other Rab GTPases

• Target conserved regions across fungal YPT11 homologs for broad species reactivity

• Identify regions that distinguish active versus inactive conformations

De novo antibody design:

• Implement AI-based CDRH3 sequence generation using germline-based templates

• Train machine learning algorithms on existing antibody-antigen complexes

• Generate candidate sequences optimized for:

  • Specificity to unique YPT11 regions

  • Minimal cross-reactivity with mammalian Rabs

  • Ability to distinguish native versus post-translationally modified forms

Production optimization:

• Design expression constructs optimized for high-yield recombinant antibody production

• Implement high-throughput screening methodologies for candidate evaluation

• Engineer antibodies with enhanced stability and reduced aggregation propensity

• Develop site-specific conjugation strategies for applying antibodies in various detection methods

Validation framework:

• Employ multiplexed assays to simultaneously evaluate multiple candidates

• Implement automated image analysis to quantify antibody performance metrics

• Validate across multiple yeast species and strains

• Test under various fixation and preparation conditions for robust performance

This AI-guided approach represents a significant advancement over traditional antibody development methods, potentially yielding higher-specificity reagents for studying low-abundance proteins like YPT11 .

How can advanced microscopy techniques enhance YPT11 localization and functional studies?

Advanced microscopy approaches offer new opportunities for YPT11 research:

Super-resolution methodologies:

• STED microscopy: Achieve 30-70 nm resolution to visualize YPT11 at organelle contact sites

• PALM/STORM: Provide single-molecule localization precision for quantitative distribution analysis

• SIM: Offer improved resolution with lower phototoxicity for live-cell imaging

• Expansion microscopy: Physically enlarge samples to resolve YPT11-associated structures

Live-cell dynamics approaches:

• Lattice light-sheet microscopy: Enable long-term 3D imaging with minimal photodamage

• FRAP/photoactivation: Measure YPT11 dynamics and mobility between compartments

• Single-particle tracking: Follow individual YPT11 molecules to reveal heterogeneous behaviors

• FRET sensors: Detect YPT11 activation state in real-time

Correlative techniques:

• CLEM (Correlative Light and Electron Microscopy): Combine fluorescence localization with ultrastructural context

• Cryo-electron tomography: Visualize YPT11-mediated contacts at molecular resolution

• FIB-SEM: Reconstruct entire cells to map global YPT11 distribution patterns

• Mass spectrometry imaging: Correlate protein localization with metabolic state

Quantitative analysis frameworks:

• Implement machine learning for automated detection of YPT11-associated structures

• Develop computational models of YPT11-dependent organelle movement

• Apply particle-based simulations to test mechanistic hypotheses

• Create standardized analysis pipelines for multi-dimensional data integration

These technologies can overcome current limitations in studying low-abundance and transiently localized proteins like YPT11, potentially resolving longstanding questions about its precise subcellular distribution and mode of action.

What is the potential relevance of YPT11 research for understanding human mitochondrial diseases?

While YPT11 is a yeast protein, its study has broader implications for human disease research:

Evolutionary conservation of mitochondrial transport:

• Fundamental principles of mitochondrial positioning are conserved from yeast to humans

• Human Myo19 and Rab proteins serve analogous functions to yeast Myo2p and YPT11

• Insights from yeast models can illuminate conserved molecular mechanisms

• Diseases involving mitochondrial mislocalization may share underlying principles with yeast mutants

Relevance to specific disease categories:

• Neurodegenerative disorders: Proper mitochondrial positioning is critical in neuronal cells

• Muscular diseases: Muscle cells require precise mitochondrial distribution for function

• Age-related pathologies: Mitochondrial inheritance quality control impacts aging processes

• Metabolic disorders: Organelle positioning affects cellular energy distribution

Translational research opportunities:

• Use YPT11 regulation principles to develop screening assays for mitochondrial transport modulators

• Apply insights from YPT11-Myo2p interactions to design peptide-based inhibitors for human counterparts

• Develop heterologous screening systems expressing human orthologs in yeast models

• Create chimeric proteins to identify functional conservation between yeast and mammalian systems

Future research directions:

• Identify human proteins that functionally complement ypt11Δ in yeast

• Compare mechanisms of regulation between YPT11 and mammalian Rabs

• Investigate whether YPT11 principles apply to specialized cells with asymmetric mitochondrial inheritance

• Explore therapeutic approaches targeting mitochondrial positioning based on YPT11 mechanisms

This translational perspective highlights how fundamental research on yeast YPT11 contributes to our understanding of human disease mechanisms and potential therapeutic approaches.